Introduction
Published reviews of bacterial meningitis incidence and case fatality hide the true impact of bacterial meningitis on families and communities. Survivors of bacterial meningitis are at risk from long-term disabling sequelae and impaired quality of life, 1 but disabled children and adults are hidden from view in many societies, subjected to stigma and neglect, and undercounted in national and international statistics. 2 Few data sources are available for paediatricians and public-health researchers to assess the long-term risk of disability associated with bacterial meningitis across countries and regions. There is also little information about the severity and distribution of the diff erent types of sequelae. Additionally, the fi nancial burden that families incur in caring for disabled individuals is commonly not calculated or is underestimated. 3 Data are especially poor from low-income countries, where the risks of infection are highest and care is least accessible. Indeed, previous systematic reviews of the long-term outcomes from bacterial meningitis focused on studies from high-income countries. 1, 4 The risk of sequelae from bacterial meningitis has probably changed since these systematic reviews were published because of improvements in antibiotics and supportive therapies to treat acute episodes of bacterial meningitis. Clinicians are now using highly sensitive tests to diagnose long-term disabling sequelae that would have previously remained undetected. Additionally, coverage of conjugate vaccines against the main causes of bacterial meningitis (Haemophilus infl uenzae type b [Hib], Streptococcus pneumoniae [pneumococcus] , and Neisseria meningitidis [meningococcus]) has increased. 5 These factors might infl uence risks of sequelae in diff erent ways.
Our aims were to estimate the risks of major and minor sequelae caused by bacterial meningitis, to estimate the distribution of the diff erent types of sequelae, and to compare sequelae risk by region and gross national income (GNI).
Methods

Search strategy and selection criteria
The initial search of Medline and WHOLIS databases aimed to be as inclusive as possible, and used the search terms "meningitis, bacterial"[Mesh] AND "complications" [Subheading] , limited to human studies published between Jan 1, 1980 and Mar 1, 2008 (fi gure 1). We restricted our search up to March, 2008, to maintain consistency and comparability with other WHO Global Burden of Disease (GBD) and Child Health Epidemiology Reference Group publications aimed at producing estimates for the year 2008. 6, 7, 8 We also contacted experts and searched reference lists of articles to obtain unpublished data. There were no language restrictions.
We defi ned bacterial meningitis according to the 2001 GBD Disease Control Priorities Project (DCPP) 9 as an acute bacterial disease with sudden onset of fever, intense headache, nausea, vomiting, or neck stiff ness. The clinical diagnosis of meningitis had to be accompanied by laboratory evidence (in cerebrospinal fl uid or blood) of a recognised bacterial pathogen (eg, Hib, pneumococcus, or meningococcus). 9 We did not include tuberculous or viral diseases, because their natural history and sequelae risks are substantially diff erent from those of bacterial pathogens such as Hib, pneumococcus, and meningococcus.
A sequela was defi ned according to the GBD DCPP as a health state resulting from meningitis for which Review epidemiological estimates (incidence, prevalence, average duration) and a single average disability weight could be calculated. 9 It included all current and future functional health states (until remission to full health or death) in the natural history of the disease that impaired quality of life or activities of daily living.
The GBD DCPP has defi ned a group of severe sequelae (table 1) , which we retained for use in this study and labelled as major sequelae. 9 We also developed a set of other commonly reported minor sequelae that were less severe but still impaired quality of life and activities of daily living (table 1) . A separate category was also created to identify individuals with more than one sequela (multiple impairments), because bacterial meningitis results in parenchymal brain damage and defi cits in many diff erent domains. Multiple impairments were also stratifi ed into major and minor categories. All sequelae were allocated an International Classifi cation of Diseases, 10th edition (ICD-10) code. 10 Papers were excluded if they did not report the following: numbers of laboratory-confi rmed pathogens, a defi ned denominator of meningitis patients, sequelae of meningitis, associated health/functional states, original data; or if the papers only included neonates (ie, newborns up to 1 month of age). Neonates were excluded because the causal organisms, potential interventions (including maternal health care), and policy implications are diff erent to those for older infants, children, and adults.
GBD, major sequelae
Non-GBD, minor sequelae 
Review Data extraction
Two reviewers (KE and VSK) examined titles, abstracts, and papers independently with identical case defi nitions (table 1) , data abstraction forms, and selection criteria. Reviewers also classifi ed the studies according to WHO region (African, South East Asian, Western Pacifi c, Eastern Mediterranean, European, and American regions) and WHO mortality strata. 11 Disagreements were resolved by consensus between the two reviewers and the lead authors (KE, VSK, AC, CS). An initial review of bacterial meningitis studies indicated that sequelae were reported at either the time of discharge from hospital ("at discharge") or during the follow-up period after discharge home from hospital ("post discharge"). We decided to describe both sets of data, but to focus the main analysis on the post-discharge sequelae. This is because symptoms (eg, malaise) from acute meningitis infection persist until hospital discharge, and patients' responses to hospital neurological examinations are often suboptimum (especially cognitive and hearing examinations). More representative examinations occur after patients have had time to recover from the acute illness and return home to a familiar environment (post discharge). 12, 13 
Analyses
We fi rst described the results using medians (IQR) of the proportion of individuals with any (at least one) sequelae resulting from bacterial meningitis. Major, minor, and total (major or minor) sequelae risks were calculated separately for all-cause and pathogen-specifi c (Hib, pneumococcus, and meningococcus) meningitis.
Two types of adjustment were required to estimate the median (IQR) risk by domain (ie, risk of the diff erent types of sequelae). First, many studies reported person counts for each domain independently (eg, percentage with hearing loss, percentage with motor defi cit) and did not report the number of people with multiple impairments (eg, percentage with both hearing loss and motor defi cit). We decided to retain these studies to avoid unnecessary data loss, but to convert the counts into mutually exclusive categories (eg, percentages with only hearing loss, with only motor defi cit, with both hearing loss and motor defi cit). To do this, we selected all studies that reported both independent and mutually exclusive counts and identifi ed the mean ratio between these two indicators. These ratios were then applied to all studies that reported only independent counts so that mutually exclusive counts could be generated for all studies.
Second, many studies did not report on all domains. In some cases this was due to the design of the study (eg, some studies were only designed to assess audiological sequelae and individuals were not examined for motor defi cit or other abnormalities). In other cases, no sequelae were reported for a given domain and it was not clear whether the study had been designed to examine this domain. Domain-specifi c risks were calculated based only on the studies that examined a given domain, but all domain-specifi c risks were adjusted to ensure they summed to the estimated overall risk of experiencing at least one sequela.
We used random-eff ects meta-analysis to investigate the impact of the following covariates on risk of sequelae: WHO region, WHO mortality strata, GNI band, decade of data collection, age-group (<5 years, ≥5 years), study design (prospective, retrospective), duration of follow-up after hospital discharge, and percentage of cases with laboratory confi rmation of the pathogen. The only outcome considered in these analyses was the proportion of patients with bacterial meningitis who had at least one major sequela. Each covariate was categorical with clearly defi ned subgroups. Thus, for each covariate we fi rst did a random-eff ects meta-analysis of all available studies within the subgroups to impute estimates (eg, for age-group, we imputed estimates for patients aged <5 years and ≥5 years separately). We then did a bivariate metaregression analysis in which we examined each covariate fi tted individually as a single factor in isolation and compared estimates with the most prevalent subgroup (eg, for age-group, we compared estimates for patients aged 5 years with those aged ≥5 years). Finally, we did a multivariate analysis in which we included all important covariates (GNI band, decade of data collection, age-group, study design, duration of followup after hospital discharge, and percentage of cases with laboratory confi rmation of the pathogen) in a multivariate metaregression model and obtained fi nal estimates of the proportion of people with at least one major sequela adjusting for the eff ect of these covariates. WHO region, WHO mortality band, and GNI were highly correlated and therefore only GNI was included in this fi nal model because it was a better predictor of sequelae risk than mortality band and region. Heterogeneity was assessed by use of standard meta-analytic methods.
Results
We selected 132 studies that were suitable for inclusion (fi gure 1). The webappendix includes a full summary of the studies included. No unpublished data that satisfi ed our criteria were identifi ed. Overall, 18 183 survivors of acute bacterial meningitis were examined for sequelae in the included studies (median number of survivors per study, ). As shown in table 2, Hib was the most common cause of bacterial meningitis (35·5% of all the bacterial pathogens reported), followed by pneumococcus (19·6%), meningococcus (16·4%), and other pathogens (12·0%). Median age at meningitis episode was 29 months (IQR 13-67 months), and 106 (79%) papers reported sequelae risk in children aged under 5 years. 53 (40%) papers were from the European region, followed by the Americas (n=32), Eastern Mediterranean (n=10), Western Pacifi c (n=16), Africa (n=13), and Asia (n=8). The median (IQR) year of data collection was 1989 See Online for webappendix Review . Six (10%) post-discharge studies reported sequelae risk based on data collected after 2000. Studies with a retrospective design (n=58) were retained to avoid unnecessary loss of data, although diff erences between retrospective and prospective studies were tested in the meta-regression analysis. The median follow-up time after hospital discharge was 24 months (IQR 6-63 months). Two studies followed individuals for 16 years after the meningitis episode. 59, 127 The median loss to follow-up (14·0% [IQR 7·8-22·7%]) was similar in all WHO regions and mortality strata.
No studies reported sequelae risk in malnourished people. Two papers, from Malawi and South Africa, reported sequelae risk in HIV-infected children. 69, 112 Both studies reported that sequelae risk was twice as high in HIV-infected than in non-HIV-infected children. We included the overall sequelae risk estimates (for HIV-infected and non-HIV-infected people) in our analysis. Sequelae risks were reported for all-cause bacterial meningitis (n=87), and for patients with only Hib (n=33), pneumococcal (n=27), and meningococcal meningitis (n=35). Table 3 shows risks of sequelae at discharge and post discharge. Total (major or minor) median (IQR) risks of sequelae were similar in studies with patients assessed at hospital discharge (22·8% [12·1-29·2%]) compared with those assessed during the post-discharge follow-up period (19·9% [12·3-35·3%]). In the post-discharge studies in which major (n=58) and minor (n=37) risks were included, the median (IQR) risks of at least one sequela were 12·8% (7·2-21·1%) and 8·6% (4·4-15·3%), respectively.
The median (IQR) risk of at least one major sequela was 24·7% (16·2-35·3%) in pneumococcal meningitis, 9·5% (7·1-15·3%) in Hib, and 7·2% (4·3-11·2%) in meningococcal meningitis (table 3) . There was a 2·5 times greater risk of at least one major sequela in the nine studies that compared pneumococcal and Hib meningitis (risk ratio 2·49 [95% CI 1·87-3·31]). 14, 17, 34, 39, 43, 47, 49, 52, 67 However, there were no signifi cant diff erences between meningococcal and Hib meningitis (risk ratio 0·92 [95% CI 0·66-1·29]).
Unadjusted and adjusted median (IQR) risks of the diff erent types of major and minor sequelae are shown in table 3. Only 20 (15%) studies assessed all seven domains. 30 (23%) studies only assessed hearing and 81 (61%) did not assess cognitive defi cit. All domain-specifi c risks were highest for pneumococcus, which was associated with a median (IQR) risk of major hearing loss of 9·9% (8·1-12·3%), which was higher than hearing loss due to Hib (4·5% [2·2-6·1%]) and meningococcus (4·1% [2·3-7·2%]).
The most common types of major sequelae were hearing loss (33·6%), followed by seizures (12·6%), motor defi cit (11·6%), cognitive impairment (9·1%), hydrocephalus (7·1%), and visual disturbance (6·3%). 470 (19·7%) individuals were reported to have multiple sequelae. The most common multiple impairment combinations were cognitive defi cit plus hearing loss (39·1%), cognitive defi cit plus motor impairment (21·1%), and cognitive defi cit plus motor defi cit plus seizures (8·1%). 399 (85%) individuals were reported to have a cognitive defi cit in combination with one or more other domains: 56·5% with a motor defi cit, 61·1% with a hearing defi cit.
The risk of at least one major sequela was almost three times greater in the WHO African region (pooled risk estimate 25·1% [95% CI 18·9-32·0%]) and southeast Asian region (21·6% [95% CI 13·1-31·5%]) compared with the European region (9·4% [95% CI 7·0-12·3%]; fi gure 2). There was also a progressively higher risk of major sequelae as WHO mortality strata increased (fi gure 3); risk of a major sequela was three times greater in countries in the highest mortality stratum (stratum E, 29·1% [95% CI 20·9-37·9%]) than in those in the lowest stratum (stratum A, 9·1% [95% CI 7·2-11·1%]). Table 4 shows the results from the meta-regression analysis of the eff ect of important covariates on the risk of at least one major sequelae. Because WHO region, WHO mortality band, and GNI were highly correlated, only GNI was included in the fi nal analysis because it was a better predictor of sequelae risk than mortality band and region. Countries in the poorest GNI band (<US$1500 per head) had a much higher risk of major sequelae than the countries in the richest band (≥$45 000 per head). The risk of a major sequela was also signifi cantly higher in people aged less than 5 years compared with those aged 5 years or more. There were 15 1981 Switzerland 51 65·3 0·04 (0·0-0·11) Schaad 16 1982 Switzerland 78 65·3 0·15 (0·08-0·24) Baselga 17 1985 Spain 47 32 0·32 (0·20-0·46) Fortnum 18 1985 UK 202 45·4 0·07 (0·04-0·11) Lutsar 19 1986 Estonia 84 14·3 0·06 (0·02-0·12) Kaaresen 20 1986 Norway 88 87·1 0·16 (0·09-0·24) Kilpi 21 1987 Finland 276 48·1 0·07 (0·04-0·11) Berg 22 1988 Sweden 468 50·9 0·02 (0·01-0·04) Kilpi 23 1989 Finland 115 48·1 0·07 (0·03-0·12) Duclaux 24 1989 France 116 42·3 0·07 (0·03-0·12) Katona 25 1989 Hungary 109 12·8 0·37 (0·28-0·46) Wilken 26 1990 Germany 25 42·4 0·08 (0·01-0·22) Lutschg 27 1991 Switzerland 51 65·3 0·00 (0·00-0·04) Palla 28 1991 Italy 20 35·2 0·20 (0·06-0·40) Oostenbrink 29 1992 Netherlands 101 50·2 0·11 (0·06-0·18) Francois 30 1992 France 39 42·3 0·03 (0·00-0·10) Biesheuvel 31 1993 Netherlands 168 50·2 0·13 (0·08-0·18) Koomen 32 1993 Netherlands 680 50·2 0·12 (0·10-0·15) Richardson 
Review Discussion
We reported a median overall risk of long-term disabling sequelae in meningitis survivors after discharge from hospital of 20%. Risks of at least one major post discharge sequela ranged from 9% to 25% across the WHO regions, and were almost three times higher in Africa and Asia than in Europe. Major sequelae risk also increased signifi cantly as GNI per head decreased. The overall global risk was similar to that found in previous reviews, 1, 4 but our study diff ered by reporting disparities in risk between high-income and low-income countries.
Hearing loss was the most common type of sequela. Motor defi cit, seizures, and cognitive defi cits were also important. 20% of the impairments were reported to involve multiple domains; cognitive defi cit plus hearing loss or motor defi cit was the most commonly reported combination. Paediatricians are well aware that bacterial meningitis can result in complex, multifaceted syndromes; parenchymal brain injury can result in normal structural appearance, diff use oedema, focal lesions, and gross cerebral necrosis. 13 However, no other studies have reported such high risks of multiple impairments from bacterial meningitis. The distribution of the diff erent types of sequelae seemed similar for Hib, pneumococcus, and meningococcus, suggesting that the organisms might cause similar intracranial pathological processes.
Long-term disabling sequelae were particularly common in people with pneumococcal meningitis. This has been reported in other studies, 1, 4, 130 and is due to the particular virulence of the pneumococcal organism. 13 Hib was the most common cause of bacterial meningitis, because many studies included data from the pre-Hibvaccination era. The risks of sequelae for Hib and meningococcal meningitis diff ered little.
There also seems to have been little change in the risk of long-term disabling sequelae over the past three decades. In particular, there was no change in risk over time for specifi c causes (Hib, pneumococcus, and meningococcus). This might be due to the increased use of highly sensitive tests to diagnose long-term disabling sequelae. An alternative explanation is that advances in medical care and new technologies (which should be reducing sequelae risk) are not reaching the people most in need. Further research and investigation into these issues is needed.
Our review had several limitations. First, only 60% of studies were prospective, and almost 20% of individuals in these studies were lost to follow-up. Families of disabled people might be more likely to suff er from fi nancial or emotional stresses than families of non-disabled people, and so might be more likely to move or migrate out of the study area and become lost to follow-up. 146 Conversely, those who have few or no sequelae might be more likely to become lost to follow-up due to lack of interest in the study or no perceived benefi t in continued participation.
Additionally, disabled people have a higher mortality risk than non-disabled people, and some will have died before follow-up, leaving the survivors with a spuriously low occurrence of sequelae. 146 This survivor bias is particularly important for African and Asian countries with high case fatality after hospital discharge. 147 Furthermore, all studies included in our study were hospital based. Hospital studies are biased towards patients with better access to acute and long-term health care. 148 These people tend to have higher socioeconomic status and lower sequelae risk than those with poor access to care. 4 Second, our studies were very heterogeneous and this was obvious in our metaregression analysis. This was due to the wide range of data sources retained, particularly in studies from low-income countries. However, we did adjust our meta-analyses for important variables (ie, age, study design, GNI, duration of follow-up, year of data collection, percentage of cases laboratory confi rmed) and presented both unadjusted and adjusted estimates.
Third, observational studies are prone to problems with misclassifi cation. 149 Only 15% of the studies examined all the sequelae domains; thus, the number of individuals with multiple impairments is likely to have been underestimated. Moreover, only two studies assessed cognitive and visual domains in the African and Asian regions, and these risks are likely to have been underestimated. However, our abstractors used strict case defi nitions, and we adjusted the domain-specifi c sequelae so that they represented mutually exclusive counts of children.
Finally, few studies assessed the infl uence of important potential risk factors. No studies documented the eff ect of malnutrition and only two studies examined the role Analysis was by random-eff ects meta-analysis. Mortality strata were created by WHO 11 to defi ne countries in terms of health status and mortality rather than income: A=very low child mortality; B=low child mortality plus low adult mortality; C=low child mortality plus high adult mortality; D=high child mortality plus high adult mortality; E=high child mortality plus very high adult mortality. 
0·4 Proportion with at least one major sequela 0·5 Review of HIV in the development of neurodevelopmental sequelae. We were not able to examine the eff ect of other important risk factors, such as prematurity or low birth weight, because few studies provided suffi cient data to examine these issues separately. We were also unable to report on the underlying level of neurodevelopmental disability in specifi c regions because most studies did not report disability risk in healthy community control groups, nor the developmental status of participants before the acute attack of meningitis.
Our analyses focused on the risk of major sequelae in patients after they were discharged home from hospital. The natural healing process after the acute meningitis episode leads clinicians to expect a decrease in the proportion of people with sequelae from bacterial meningitis over time. However, we found little change in sequelae risk during the post-discharge follow-up period. Other systematic reviews have also reported similar fi ndings, 1 and this might be due to problems with sequelae ascertainment in the included studies. Indeed, the longer the follow-up period, the longer the time available for disabled people to migrate or die or refuse to participate (ie, become lost to follow-up). Additionally, as people (especially children) become older, they become easier to examine and several sequelae that are not able to be ascertained in younger people can become evident at an older age (eg, motor impairments can manifest as fl oppiness in infants but spasticity in older children, tests for cognitive defi cits and hearing loss are very diffi cult to administer in young children). Prospective studies with long-term follow-up and repeat examinations of the same people provide the most useful data. A large prospective UK study reported that almost 16% of children followed up to age 5 years had a signifi cant disability. 34 Review impairments and 30% of children with cognitive and behavioural problems at 12 years after the meningitis episode. 57, 98 However, an older US study reported a sharp decrease in neurological and audiological abnormalities as duration of follow-up increased (42% of children at hospital discharge, 38% at 1 month, and 5% at 12 months after the acute meningitis episode). 150 We also reported that the risk of sequelae in children aged less than 5 years was twice as high as for older people. This fi nding is consistent with other studies that used multivariate regression models and reported increased odds of meningitis sequelae in infants compared to older people. 151 Other researchers have described high risk of sequelae in infants who develop acute bacterial meningitis in the early months of life. 4, 34, 152 This study has important implications for policy development. We have emphasised the diff erentials in the risk of sequelae after bacterial meningitis between high-income and low-income countries. There are many reasons for these disparities, including delay in receiving eff ective hospital antibiotic treatment for the acute meningitis episode. 21, 153 People in low-income countries often have to travel much further to a health-care facility than those in high-income countries. 154 Costs of hospital care can be prohibitive for many families and might result in signifi cant delays in presentation to hospital. 154 There is also an increasing problem of suboptimum quality of care once people are admitted to hospital in low-income countries. 155 Reasons include emerging antibiotic resistance and increased use of low-cost generic parenteral antibiotics of low potency (ie, third-generation cephalosporins). 155, 156 Treatment failures from prescribed antibiotics are becoming increasingly common and must be addressed by tighter manufacturing regulations. 156 The results of this study highlight the importance of both primary and secondary prevention. Many of the reported disabilities could have been averted. Highly effi cacious conjugate vaccines are now available for the three major causes of bacterial meningitis in children aged less than 5 years (Hib, pneumococcus, and meningococcus). Vaccines for other important causes of meningitis are also needed (eg, group B streptococcus). Additionally, timely access to follow-up services for disabled people (such as antiepileptics, hearing assessment, speech therapy, physiotherapy, and occupational therapy) can reduce the severity of sequelae and improve quality of life. 2 However, these services are often not available in low-income countries. For example, a recent study in Senegal reported that no children with bacterial meningitis received postdischarge follow-up care from a health-care professional 12 months after the acute bacterial meningitis episode (Griffi ths UK, unpublished). All people who are admitted to hospital with a serious neurological infection such as bacterial meningitis require close long-term follow-up after hospital discharge. 13 Inpatient hospital audit and peer review has improved markedly over the past decade, 157 but post-discharge care has not received the same attention. Global, regional, and national estimates should be revised to indicate the true burden of long-term disabling sequelae from bacterial meningitis. These data should be disseminated so that appropriate services and follow-up care can be planned and implemented. This information should also be used in advocacy to improve basic services such as vaccination, timely access to hospital care, hospital treatment, and long-term community-based follow-up for people with meningitis sequelae.
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